☆ 4.4 Article

Lasting Complete Clinical Response of a Recurring Cutaneous Squamous Cell Carcinoma With MEK Mutation and PIK3CA Amplification Achieved by Dual Trametinib and Metformin Therapy

JCO PRECISION ONCOLOGY (2022)

Get Full Text
Add to Collection

Journal

JCO PRECISION ONCOLOGY
Volume 6, Issue -, Pages -

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1200/PO.21.00344

Keywords

-

Categories

Oncology

Funding

  1. Hungarian Innovation Agency [2019-1.1.1PIACI-KFI-2019-00367]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.